BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3260283)

  • 1. Monoclonal anti-acetylcholine receptor antibodies as probes for human acetylcholine-receptor in myasthenia gravis.
    Vincent A; Whiting PJ; Heidenreich F; Roberts A
    J Recept Res; 1988; 8(1-4):143-59. PubMed ID: 3260283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor antibodies and anti-idiotypic antibodies produced in blood lymphocyte cultures from patients with myasthenia gravis.
    Lefvert AK; Sundén H; Holm G
    Scand J Immunol; 1986 Jun; 23(6):655-62. PubMed ID: 3715409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ligand antibodies as potential autoantigens: in vitro and in vivo characteristics of anti-bungarotoxin antibodies in the idiotype network.
    Pachner AR; Itano AA; McCallum RM; Ricalton NS
    Autoimmunity; 1991; 10(2):145-52. PubMed ID: 1782327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of neonatal administration of antiidiotype antibodies on experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Graus YM; Van Breda Vriesman PJ; Tzartos S; De Baets MH
    Autoimmunity; 1991; 10(3):173-9. PubMed ID: 1756222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-acetylcholine receptor antibody related idiotypes in myasthenia gravis.
    Lefvert AK
    J Autoimmun; 1988 Feb; 1(1):63-72. PubMed ID: 3267109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody heterogeneity and specificity in myasthenia gravis.
    Vincent A; Whiting PJ; Schluep M; Heidenreich F; Lang B; Roberts A; Willcox N; Newsom-Davis J
    Ann N Y Acad Sci; 1987; 505():106-20. PubMed ID: 2446546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are spontaneous anti-idiotypic antibodies against anti-acetylcholine receptor antibodies present in myasthenia gravis?
    Vincent AC
    J Autoimmun; 1988 Apr; 1(2):131-42. PubMed ID: 3252806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies of a predominant idiotype.
    Killen JA; Hochschwender SM; Lindstrom JM
    J Neuroimmunol; 1985 Aug; 9(3-4):229-41. PubMed ID: 4019748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients.
    Eng H; Lefvert AK
    Ann Inst Pasteur Immunol; 1988; 139(5):569-80. PubMed ID: 3264701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies.
    Roberts A; Lang B; Vincent A; Newsom-Davis J
    Autoimmunity; 1992; 12(1):53-60. PubMed ID: 1617105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
    Pachner AR; Sourojon M; Fuchs S
    J Neuroimmunol; 1986 Sep; 12(3):205-14. PubMed ID: 3488332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.
    Dwyer DS; Bradley RJ; Urquhart CK; Kearney JF
    Nature; 1983 Feb 17-23; 301(5901):611-4. PubMed ID: 6402708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiotypic network connectivity and a possible cause of myasthenia gravis.
    Dwyer DS; Vakil M; Kearney JF
    J Exp Med; 1986 Oct; 164(4):1310-8. PubMed ID: 2428915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
    Agius MA; Geannopoulos CJ; Fairclough RH; Richman DP
    J Immunol; 1988 Jan; 140(1):62-8. PubMed ID: 3257231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotypic network in myasthenia gravis demonstrated by human monoclonal B-cell lines.
    Lefvert AK; Holm G
    Scand J Immunol; 1987 Nov; 26(5):573-8. PubMed ID: 3500505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The start of an autoimmune disease: idiotypic network during early progression of myasthenia gravis.
    Lefvert AK
    Ann Inst Pasteur Immunol; 1988; 139(6):633-43. PubMed ID: 3264703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.